BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: David S, Mathews V. Mechanisms and management of coagulopathy in acute promyelocytic leukemia. Thromb Res 2018;164 Suppl 1:S82-8. [PMID: 29703489 DOI: 10.1016/j.thromres.2018.01.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Roy PS, Munikoty V, Trehan A, Jain R, Bhatia P, Naseem S, Varma N, Bansal D. Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years. Pediatr Hematol Oncol 2022;:1-14. [PMID: 35849424 DOI: 10.1080/08880018.2022.2082610] [Reference Citation Analysis]
2 Shu X, Wu Q, Guo T, Yin H, Liu J. Acute Promyelocytic Leukemia Presenting With a Myeloid Sarcoma of the Spine: A Case Report and Literature Review. Front Oncol 2022;12:851406. [DOI: 10.3389/fonc.2022.851406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fodil S, Arnaud M, Vaganay C, Puissant A, Lengline E, Mooney N, Itzykson R, Zafrani L. Endothelial cells: major players in acute myeloid leukaemia. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100932] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hasegawa T, Kanayama T, Komatsu H. Acute promyelocytic leukemia complicated by iliac subperiosteal hematoma. Pediatr Int 2022;64:e15078. [PMID: 35313043 DOI: 10.1111/ped.15078] [Reference Citation Analysis]
5 Sabljic N, Pantic N, Virijevic M, Bukumiric Z, Novakovic T, Pravdic Z, Rajic J, Vidovic A, Suvajdzic N, Jaradeh M, Fareed J, Antic D, Mitrovic M. Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia. Clin Appl Thromb Hemost 2022;28:10760296221119809. [PMID: 35942712 DOI: 10.1177/10760296221119809] [Reference Citation Analysis]
6 Siegal T, Benouaich-Amiel A, Bairey O. Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities. Blood Rev 2021;:100910. [PMID: 34836656 DOI: 10.1016/j.blre.2021.100910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Varghese C, Liu VY, Immanuel T, Chien N, Green T, Chan G, Theakston E, Kalev-Zylinska M. Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients. Hematology 2021;26:215-24. [PMID: 33594940 DOI: 10.1080/16078454.2021.1882146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhao H, Sun J, Yan L, Jin B, Hou W, Cao F, Li H, Zhou J, Zhang Y. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study. Ann Hematol 2021;100:1473-83. [PMID: 33893844 DOI: 10.1007/s00277-021-04533-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Ten Cate H, Leader A. Management of Disseminated Intravascular Coagulation in Acute Leukemias. Hamostaseologie 2021;41:120-6. [PMID: 33860520 DOI: 10.1055/a-1393-8302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Farmer I, Okikiolu J, Steel M, Wanniarachchi C, Littlewood S, Gupta S, Thanigaikumar M, Oram SH, Moonim M, Kulasekararaj AG, Yeghen T. Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum. Br J Haematol 2020;190:e248-50. [PMID: 32428243 DOI: 10.1111/bjh.16864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Baldacini M, Pop R, Sattler L, Mauvieux L, Bilger K, Gantzer J, Schneider F, Beaujeux R, Simand C, Herbrecht R. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia. Br J Haematol 2020;189:1054-6. [PMID: 32369614 DOI: 10.1111/bjh.16768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
12 Naymagon L, Mascarenhas J. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented? Leuk Res 2020;94:106356. [PMID: 32445941 DOI: 10.1016/j.leukres.2020.106356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sabljić N, Mitrović M. Clinical utility of rotational thromboelastometry in detecting hemostatic disorders. Medicinski podmladak 2020;71:3-9. [DOI: 10.5937/mp71-27853] [Reference Citation Analysis]
14 Kurtin S. Interdisciplinary Management of Acute Leukemia Across the Continuum of Care. Semin Oncol Nurs 2019;35:150953. [PMID: 31748172 DOI: 10.1016/j.soncn.2019.150953] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Wu MY, Lin CH, Hou YT, Lin PC, Yiang GT, Tien YC, Yeh HC. Syncope as Initial Presentation in an Undifferentiated Type Acute Myeloid Leukemia Patient with Acute Intracranial Hemorrhage. Brain Sci 2019;9:E207. [PMID: 31434194 DOI: 10.3390/brainsci9080207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]